These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Beta amyloid imaging with positron emission tomography (PET) for evaluation of suspected Alzheimer's disease or other causes of cognitive decline. Technol Eval Cent Assess Program Exec Summ; 2013 Feb; 27(5):1-4. PubMed ID: 23589929 [No Abstract] [Full Text] [Related]
23. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Chételat G; Villemagne VL; Bourgeat P; Pike KE; Jones G; Ames D; Ellis KA; Szoeke C; Martins RN; O'Keefe GJ; Salvado O; Masters CL; Rowe CC; Ann Neurol; 2010 Mar; 67(3):317-24. PubMed ID: 20373343 [TBL] [Abstract][Full Text] [Related]
24. 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective. Kung HF; Choi SR; Qu W; Zhang W; Skovronsky D J Med Chem; 2010 Feb; 53(3):933-41. PubMed ID: 19845387 [No Abstract] [Full Text] [Related]
25. Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease. Rabinovici GD; Roberson ED Ann Neurol; 2010 Mar; 67(3):283-5. PubMed ID: 20373338 [No Abstract] [Full Text] [Related]
26. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer's Brain Tissue. Ni R; Röjdner J; Voytenko L; Dyrks T; Thiele A; Marutle A; Nordberg A J Alzheimers Dis; 2021; 80(4):1723-1737. PubMed ID: 33749648 [TBL] [Abstract][Full Text] [Related]
27. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease. Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250 [TBL] [Abstract][Full Text] [Related]
28. Compounds for imaging amyloid-β deposits in an Alzheimer's brain: a patent review. Tu P; Fu H; Cui M Expert Opin Ther Pat; 2015 Apr; 25(4):413-23. PubMed ID: 25746836 [TBL] [Abstract][Full Text] [Related]
31. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry. Kaya I; Zetterberg H; Blennow K; Hanrieder J ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443 [TBL] [Abstract][Full Text] [Related]
32. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045 [TBL] [Abstract][Full Text] [Related]
33. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H; Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152 [TBL] [Abstract][Full Text] [Related]
34. Imaging amyloid plaque in Alzheimer's disease brain with a biotinylated Aβ peptide radiopharmaceutical conjugated to an IgG-avidin fusion protein. Sumbria RK; Boado RJ; Pardridge WM Bioconjug Chem; 2012 Jun; 23(6):1318-21. PubMed ID: 22624578 [TBL] [Abstract][Full Text] [Related]
35. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains. Ono M; Watanabe R; Kawashima H; Kawai T; Watanabe H; Haratake M; Saji H; Nakayama M Bioorg Med Chem; 2009 Mar; 17(5):2069-76. PubMed ID: 19201614 [TBL] [Abstract][Full Text] [Related]
36. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging. Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773 [TBL] [Abstract][Full Text] [Related]
37. MRI for in vivo detection of amyloid plaques. Bartlett S Lancet Neurol; 2005 May; 4(5):276. PubMed ID: 15861557 [No Abstract] [Full Text] [Related]
38. The future: new methods of imaging exploration in Alzheimer's disease. Nordberg A Front Neurol Neurosci; 2009; 24():47-53. PubMed ID: 19182462 [TBL] [Abstract][Full Text] [Related]